Published in J Bone Miner Res on January 01, 2010
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica (Cairo) (2013) 1.20
The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease. J Bone Miner Res (2014) 0.89
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis. Int J Endocrinol (2014) 0.89
Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone. J Diabetes Res (2014) 0.88
Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment. Bone (2014) 0.86
H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells. Antioxid Redox Signal (2012) 0.86
Deregulation of bone forming cells in bone diseases and anabolic effects of strontium-containing agents and biomaterials. Biomed Res Int (2014) 0.85
Effects of anti-tumor necrosis factor α agents on bone. Curr Opin Rheumatol (2012) 0.84
B Cell Production of Both OPG and RANKL is Significantly Increased in Aged Mice. Open Bone J (2015) 0.79
Surface contaminants inhibit osseointegration in a novel murine model. Bone (2011) 0.78
The role of PGRN in musculoskeletal development and disease. Front Biosci (Landmark Ed) (2014) 0.77
Suppression of NF-κB activation by gentian violet promotes osteoblastogenesis and suppresses osteoclastogenesis. Curr Mol Med (2014) 0.77
Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure. Alcohol (2011) 0.77
Paracrine effects of haematopoietic cells on human mesenchymal stem cells. Sci Rep (2015) 0.75
Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity. J Orthop Res (2016) 0.75
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
Dickkopf-1 is a master regulator of joint remodeling. Nat Med (2007) 7.29
Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature (1986) 5.68
A twist code determines the onset of osteoblast differentiation. Dev Cell (2004) 5.40
Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res (2008) 2.45
Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold. Tissue Eng (2006) 2.35
Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene (2003) 2.22
p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev (2005) 2.17
The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem (2003) 2.09
Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res (2007) 1.79
Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol (1999) 1.75
Bone mass is inversely proportional to Dkk1 levels in mice. Bone (2007) 1.71
Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs (2001) 1.56
Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem (1996) 1.55
Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer (2007) 1.48
Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis (2000) 1.48
Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation (2006) 1.44
Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res (2007) 1.42
Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem (2006) 1.37
Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res (2007) 1.35
The human cost of fracture. Osteoporos Int (2005) 1.33
Fracture healing in the elderly patient. Exp Gerontol (2006) 1.32
Bone formation is impaired in a model of type 1 diabetes. Diabetes (2005) 1.32
The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone (2004) 1.31
Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation. J Biol Chem (2006) 1.31
The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab (2004) 1.29
The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. J Clin Invest (2005) 1.26
Gene expression in older rats with delayed union of femoral fractures. J Bone Joint Surg Am (2003) 1.24
High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res (2007) 1.21
Inflammatory bone destruction and osteoimmunology. J Periodontal Res (2005) 1.20
Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem (2004) 1.17
Infected nonunion of the long bones. Clin Orthop Relat Res (2005) 1.16
Experimental and clinical experience with distraction osteogenesis. Cleft Palate Craniofac J (1994) 1.15
A review of 240 patients undergoing distraction osteogenesis for congenital post-traumatic or postinfective lower limb length discrepancy. J Am Coll Surg (1996) 1.14
Skeletal effects of developmental lead exposure in rats. Toxicol Sci (2001) 1.12
The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity. J Biol Chem (2007) 1.09
Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat. J Histochem Cytochem (2002) 1.07
Histochemical and molecular analyses of distraction osteogenesis in a mouse model. J Orthop Res (1998) 1.06
Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts. J Bone Miner Res (2009) 1.05
Sustained proliferation accompanies distraction osteogenesis in the rat. J Orthop Res (1997) 1.05
Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J Bone Miner Res (2006) 1.05
Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study. Free Radic Res (2008) 1.03
Osteoneogenesis and its influencing factors during treatment with the Ilizarov method. Clin Orthop Relat Res (1996) 1.03
Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone (1989) 1.02
Inflammatory cytokines regulate proliferation of cultured human osteoblasts. Acta Orthop Scand (1997) 1.00
The osteogenic-angiogenic interface: novel insights into the biology of bone formation and fracture repair. Curr Osteoporos Rep (2008) 1.00
Management of nonunion with distraction osteogenesis. Injury (2006) 0.96
The effect of aging on distraction osteogenesis in the rat. J Orthop Res (2001) 0.96
Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis. Toxicol Appl Pharmacol (2007) 0.95
Rat model of distraction osteogenesis. J Orthop Res (1997) 0.95
p21(WAF1/CIP1) acts as a brake in osteoblast differentiation. J Bone Miner Res (2003) 0.93
Ethanol modulation of TNF-alpha biosynthesis and signaling in endothelial cells: synergistic augmentation of TNF-alpha mediated endothelial cell dysfunctions by chronic ethanol. Alcohol Clin Exp Res (2005) 0.93
Bone formation after damaging in vivo fatigue loading results in recovery of whole-bone monotonic strength and increased fatigue life. J Orthop Res (2007) 0.92
A murine model of distraction osteogenesis. Bone (2000) 0.91
Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis. Alcohol Clin Exp Res (2005) 0.89
Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab (1997) 0.89
IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats. Toxicol Sci (2004) 0.89
Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system. Exp Gerontol (2008) 0.85
p21(WAF1/CIP1) inhibits cell cycle progression but not G2/M-phase transition following methylmercury exposure. Toxicol Appl Pharmacol (2002) 0.82
TNF in combination with interferon-gamma is cytotoxic to normal, untransformed mouse and rat embryo fibroblast-like cells. Anticancer Res (1989) 0.82
Genes with greater up-regulation in the fracture callus of older rats with delayed healing. J Orthop Res (2007) 0.82
Osteoporosis in men: pathophysiology, evaluation, and therapy. Curr Opin Rheumatol (2002) 0.76
Impacts of biological invasions: what's what and the way forward. Trends Ecol Evol (2012) 7.99
Restoration of ecosystem services and biodiversity: conflicts and opportunities. Trends Ecol Evol (2011) 2.31
Maternal obesity at conception programs obesity in the offspring. Am J Physiol Regul Integr Comp Physiol (2007) 2.08
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab (2005) 1.86
Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res (2006) 1.84
IL-1 family nomenclature. Nat Immunol (2010) 1.79
Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation. Mol Cell (2013) 1.67
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res (2005) 1.65
Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun (2003) 1.60
Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res (2002) 1.46
Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone (2006) 1.45
Diet-derived phenolic acids regulate osteoblast and adipocyte lineage commitment and differentiation in young mice. J Bone Miner Res (2014) 1.43
Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology (2006) 1.41
The economics of restoration: looking back and leaping forward. Ann N Y Acad Sci (2014) 1.39
A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol (2007) 1.39
Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology. Clin Chem Lab Med (2005) 1.37
Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab (2010) 1.35
GLUT1CBP(TIP2/GIPC1) interactions with GLUT1 and myosin VI: evidence supporting an adapter function for GLUT1CBP. Mol Biol Cell (2005) 1.35
Bone formation is impaired in a model of type 1 diabetes. Diabetes (2005) 1.32
Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane. Role of TRB3 in inhibition of Akt/protein kinase B activation. J Biol Chem (2006) 1.32
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine (2008) 1.30
Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J Nutr (2004) 1.29
Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab (2003) 1.28
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab (2012) 1.25
Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res (2008) 1.23
Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care (2007) 1.23
Postsynaptic targeting of alternative postsynaptic density-95 isoforms by distinct mechanisms. J Neurosci (2002) 1.22
Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exp Res (2007) 1.21
Maternal overweight programs insulin and adiponectin signaling in the offspring. Endocrinology (2010) 1.21
The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res (2002) 1.21
Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight. J Bone Miner Res (2008) 1.20
Obesity reduces bone density associated with activation of PPARγ and suppression of Wnt/β-catenin in rapidly growing male rats. PLoS One (2010) 1.20
Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. Am J Pathol (2008) 1.19
The health implications of soy infant formula. Am J Clin Nutr (2009) 1.19
Optic nerve aplasia in an infant with congenital hypopituitarism and posterior pituitary ectopia. Arch Ophthalmol (2004) 1.19
Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin Exp Res (2003) 1.18
Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr (2006) 1.15
N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr (2008) 1.15
The açaí flavonoid velutin is a potent anti-inflammatory agent: blockade of LPS-mediated TNF-α and IL-6 production through inhibiting NF-κB activation and MAPK pathway. J Nutr Biochem (2011) 1.13
SUMO wrestling with type 1 diabetes. J Mol Med (Berl) (2005) 1.13
The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun (2010) 1.13
Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts. J Pharmacol Exp Ther (2006) 1.12
Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun (2005) 1.11
Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone (2010) 1.11
Physiologic and genomic analyses of nutrition-ethanol interactions during gestation: Implications for fetal ethanol toxicity. Exp Biol Med (Maywood) (2006) 1.11
Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. PLoS One (2011) 1.10
Maternal obesity enhances white adipose tissue differentiation and alters genome-scale DNA methylation in male rat offspring. Endocrinology (2013) 1.09
Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med (2005) 1.08
sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol Microbiol (2012) 1.08
Developmental status of 1-year-old infants fed breast milk, cow's milk formula, or soy formula. Pediatrics (2012) 1.08
Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab (2006) 1.08
Immunohistochemical study of osteopontin expression during distraction osteogenesis in the rat. J Histochem Cytochem (2002) 1.07
Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr (2009) 1.07
Aging alters the skeletal response to disuse in the rat. Am J Physiol Regul Integr Comp Physiol (2006) 1.06
Maternal obesity promotes a proinflammatory signature in rat uterus and blastocyst. Endocrinology (2011) 1.06
Multiple interfaces in self-assembled breath figures. Chem Commun (Camb) (2014) 1.06
Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med (Maywood) (2008) 1.06
Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology (2007) 1.06
Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts. J Bone Miner Res (2009) 1.05
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab (2013) 1.05
Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr (2002) 1.05
Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J Bone Miner Res (2006) 1.05
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone (2005) 1.03
Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol (2010) 1.03
Development of toxicity identification evaluation procedures for pyrethroid detection using esterase activity. Environ Toxicol Chem (2004) 1.03
A novel mouse model for the study of the inhibitory effects of chronic ethanol exposure on direct bone formation. Alcohol (2006) 1.02